Renoprotective effects of renin–angiotensin–aldosterone system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysis. Reply to Catalá-López F [letter]
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.